CCR2 silencing in sensory neurons blocks bone cancer progression
Élora Midavaine, Jérôme Côté, Alexandra Trépanier, Sakeen W. Kashem, Marc‐André Dansereau, Jean‐Michel Longpré, Martine Charbonneau, Claire M. Dubois, Ashley M. Jacobi, Scott D. Rose, Mark A. Behlke, Philippe Sarret
This study shows that silencing CCR2 in sensory neurons blocks bone cancer progression and alleviates pain by disrupting neuropeptide-driven tumor growth.
bioRxiv · May 29, 2024 · PreprintNeuroscience